SB

Stephen Bloch

Chief Executive Officer at EvolveImmune Therapeutics

Westport, Connecticut

Overview

Work Experience

ET

EvolveImmune Therapeutics

  • Chief Executive Officer

    2019 - Current

Allyx Therapeutics, Inc.

  • Chief Executive Officer

    2019

CP

Canaan Partners

  • General Partner

    2002

LC

Liquidia Corporation

  • Chairman Of The Board

    2018

Radiology Management Sciences

  • Chief Executive Officer

    1995 - 2002

Arthur D. Little

  • consultant

    1994 - 1995

Education

Investments

Truveris

Series C

Total Funding: $67M

Genome Medical

Series A

Total Funding: $97M

Liquidia Technologies

Series C

Total Funding: $77M

Onkos Surgical

Series B

Total Funding: $18M

Relevant Websites